Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Gene expression profiling for prediction of clinical characteristics of breast cancer.

Huang E, West M, Nevins JR.

Recent Prog Horm Res. 2003;58:55-73. Review.

PMID:
12795414
2.

Predicting features of breast cancer with gene expression patterns.

Lu X, Lu X, Wang ZC, Iglehart JD, Zhang X, Richardson AL.

Breast Cancer Res Treat. 2008 Mar;108(2):191-201. doi: 10.1007/s10549-007-9596-6. Epub 2007 May 22.

PMID:
18297396
3.

Challenges in projecting clustering results across gene expression-profiling datasets.

Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.

PMID:
18000217
4.

Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.

Lancashire LJ, Rees RC, Ball GR.

Artif Intell Med. 2008 Jun;43(2):99-111. doi: 10.1016/j.artmed.2008.03.001. Epub 2008 Apr 16.

PMID:
18420392
5.

Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

Gruvberger S, Ringnér M, Chen Y, Panavally S, Saal LH, Borg A, Fernö M, Peterson C, Meltzer PS.

Cancer Res. 2001 Aug 15;61(16):5979-84.

6.

Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.

Yang F, Foekens JA, Yu J, Sieuwerts AM, Timmermans M, Klijn JG, Atkins D, Wang Y, Jiang Y.

Oncogene. 2006 Mar 2;25(9):1413-9.

PMID:
16261164
7.

Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis.

Nishidate T, Katagiri T, Lin ML, Mano Y, Miki Y, Kasumi F, Yoshimoto M, Tsunoda T, Hirata K, Nakamura Y.

Int J Oncol. 2004 Oct;25(4):797-819.

PMID:
15375528
8.

Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.

Harrell JC, Dye WW, Harvell DM, Pinto M, Jedlicka P, Sartorius CA, Horwitz KB.

Cancer Res. 2007 Nov 1;67(21):10582-91.

9.

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M.

J Natl Cancer Inst. 2006 Feb 15;98(4):262-72.

PMID:
16478745
10.

Predicting the clinical status of human breast cancer by using gene expression profiles.

West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11462-7. Epub 2001 Sep 18.

11.

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.

Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.

Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31.

PMID:
18668363
12.

A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.

Yu K, Ganesan K, Miller LD, Tan P.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3288-96.

13.

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.

Clin Cancer Res. 2005 May 1;11(9):3315-9.

14.

[Gene expression profiling of ER+ breast cancers: to discriminate the poor prognosis tumors or to define the most suitable treatment?].

Chanrion M, Darbon JM.

Bull Cancer. 2008 May;95(5):513-8. doi: 10.1684/bdc.2008.0646. Review. French.

15.

Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications.

Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):878s-83s. Review.

16.

Identification of a robust gene signature that predicts breast cancer outcome in independent data sets.

Korkola JE, Blaveri E, DeVries S, Moore DH 2nd, Hwang ES, Chen YY, Estep AL, Chew KL, Jensen RH, Waldman FM.

BMC Cancer. 2007 Apr 11;7:61.

17.

Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.

Gruvberger-Saal SK, Edén P, Ringnér M, Baldetorp B, Chebil G, Borg A, Fernö M, Peterson C, Meltzer PS.

Mol Cancer Ther. 2004 Feb;3(2):161-8.

18.

Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer.

Sorbello V, Fuso L, Sfiligoi C, Scafoglio C, Ponzone R, Biglia N, Weisz A, Sismondi P, De Bortoli M.

Int J Biol Markers. 2003 Apr-Jun;18(2):123-9.

PMID:
12841681
19.
20.

Supplemental Content

Support Center